|
2020 Conference Publication Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infectionHasnain, S., Wang, R., Taylor, S., Wong, K. Y., Moniruzzaman, M., Upham, J., Spann, K., Mcguckin, M. A., Burr, L. and Phipps, S. (2020). Harnessing the therapeutic potential of interleukin-22 in neonatal respiratory viral infection. TSANZSRS 2020 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, Melbourne, VIC, Australia, 27–31 March 2020. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/resp.13777 |
|
2019 Journal Article Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?Visser, Simone K., Bye, Peter T. P., Fox, Greg J., Burr, Lucy D., Chang, Anne B., Holmes-Liew, Chien-Li, King, Paul, Middleton, Peter G., Maguire, Graeme P., Smith, Daniel, Thomson, Rachel M., Stroil-Salama, Enna, Britton, Warwick J. and Morgan, Lucy C. (2019). Management of Australian adults with bronchiectasis in tertiary care: evidence-based or access-driven?. Lung, 197 (6), 803-810. doi: 10.1007/s00408-019-00280-x |
|
2019 Journal Article Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysisChalmers, James D, Boersma, Wim, Lonergan, Mike, Jayaram, Lata, Crichton, Megan L, Karalus, Noel, Taylor, Steven L, Martin, Megan L, Burr, Lucy D, Wong, Conroy and Altenburg, Josje (2019). Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis. Lancet Respiratory Medicine, 7 (10), 845-854. doi: 10.1016/s2213-2600(19)30191-2 |
|
2019 Journal Article The impact of CFTR modulator therapies on CF airway microbiologyRogers, Geraint B., Taylor, Steven L., Hoffman, Lucas R. and Burr, Lucy D. (2019). The impact of CFTR modulator therapies on CF airway microbiology. Journal of Cystic Fibrosis, 19 (3), 359-364. doi: 10.1016/j.jcf.2019.07.008 |
|
2019 Journal Article Australian adults with bronchiectasis: the first report from the Australian bronchiectasis registryVisser, Simone K., Bye, Peter T.P., Fox, Greg J., Burr, Lucy D., Chang, Anne B., Holmes-Liew, Chien-Li, King, Paul, Middleton, Peter G., Maguire, Graeme P., Smith, Daniel, Thomson, Rachel M., Stroil-Salama, Enna, Britton, Warwick J. and Morgan, Lucy C. (2019). Australian adults with bronchiectasis: the first report from the Australian bronchiectasis registry. Respiratory Medicine, 155, 97-103. doi: 10.1016/j.rmed.2019.07.016 |
|
2019 Journal Article Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung diseaseTong, Koliarne, Barker, Daniel, France, Megan, Burr, Lucy, Greville, Hugh, Visser, Simone, Middleton, Peter, Wainwright, Claire, Dorahy, Douglas and Wark, Peter (2019). Lumacaftor/ivacaftor reduces exacerbations in adults homozygous for Phe508del mutation with severe lung disease. Journal of Cystic Fibrosis, 19 (3), 415-420. doi: 10.1016/j.jcf.2019.12.006 |
|
2019 Conference Publication Relating Airway Microbiota Composition to Nontuberculous Mycobacterial Infections in Adult Bronchiectasis PatientsThomson, R., Scoleri, G., Taylor, S., Leong, L., Burr, L. and Rogers, G. (2019). Relating Airway Microbiota Composition to Nontuberculous Mycobacterial Infections in Adult Bronchiectasis Patients. International Conference of the American-Thoracic-Society, Dallas Tx, May 17-22, 2019. NEW YORK: AMER THORACIC SOC. doi: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1035 |
|
2018 Journal Article Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gutWang, Yanan, Leong, Lex E.X., Keating, Rebecca L., Kanno, Tokuwa, Abell, Guy C.J., Mobegi, Fredrick M., Choo, Jocelyn M., Wesselingh, Steve L., Mason, A. James, Burr, Lucy D. and Rogers, Geraint B. (2018). Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut. Gut Microbes, 10 (3), 1-15. doi: 10.1080/19490976.2018.1534512 |
|
2018 Journal Article VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del allelesKeating, Dominic, Marigowda, Gautham, Burr, Lucy, Daines, Cori, Mall, Marcus A., McKone, Edward F., Ramsey, Bonnie W., Rowe, Steven M., Sass, Laura A., Tullis, Elizabeth, McKee, Charlotte M., Moskowitz, Samuel M., Robertson, Sarah, Savage, Jessica, Simard, Christopher, Van Goor, Fredrick, Waltz, David, Xuan, Fengjuan, Young, Tim and Taylor-Cousar, Jennifer L. (2018). VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles. New England Journal of Medicine, 379 (17), 1612-1620. doi: 10.1056/NEJMoa1807120 |
|
2018 Journal Article PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa Burr, Lucy D., Rogers, Geraint B., Chen, Alice C.-H., Taylor, Steven L., Bowler, Simon D., Keating, Rebecca L., Martin, Megan L., Hasnain, Sumaira Z. and McGuckin, Michael A. (2018). PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa . PLoS ONE, 13 (8) e0202296, e0202296. doi: 10.1371/journal.pone.0202296 |
|
2018 Journal Article Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategyTaylor, Steven L., Leong, Lex E. X., Mobegi, Fredrick M., Choo, Jocelyn M., Burr, Lucy D., Wesselingh, Steve and Rogers, Geraint B. (2018). Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy. Multidisciplinary Respiratory Medicine, 13 (S1) 30, 30. doi: 10.1186/s40248-018-0140-9 |
|
2018 Journal Article Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasisChoo, Jocelyn M., Abell, Guy C. J., Thomson, Rachel, Morgan, Lucy, Waterer, Grant, Gordon, David L., Taylor, Steven L., Leong, Lex E. X., Wesselingh, Steve L., Burr, Lucy D. and Rogers, Geraint B. (2018). Impact of long-term erythromycin therapy on the oropharyngeal microbiome and resistance gene reservoir in non-cystic fibrosis bronchiectasis. mSphere, 3 (2) e00103-18, e00103-18. doi: 10.1128/mSphere.00103-18 |
|
2017 Other Outputs An investigation into the effect of erythromycin on Pseudomonas aeruginosa quorum sensing in non-cystic fibrosis bronchiectasisBurr, Lucy Davina (2017). An investigation into the effect of erythromycin on Pseudomonas aeruginosa quorum sensing in non-cystic fibrosis bronchiectasis. PhD Thesis, School of Medicine, The University of Queensland. doi: 10.14264/uql.2017.836 |
|
2017 Conference Publication The Australasian Bronchiectasis Registry - Early Steps in Mapping the Impact of Bronchiectasis in Australia and New ZealandVisser, Simone, Allan, Heather, Burr, Lucy, Chang, Anne, Holmes-Liew, Chien-Li, Hunter, Cameron, Jackson, Dan, King, Paul, Maguire, Graeme, Middleton, Peter, Smith, Daniel, Thomson, Rachel, Waterer, Grant, Wong, Conroy and Morgan, Lucy (2017). The Australasian Bronchiectasis Registry - Early Steps in Mapping the Impact of Bronchiectasis in Australia and New Zealand. The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ) Annual Scientific Meeting, Canberra, Australia, 24–28 March 2017. Richmond, VIC Australia: Wiley. |
|
2017 Conference Publication The Australasian Bronchiectasis Registry - Early Steps In Mapping The Impact Of Bronchiectasis In Australia And New ZealandVisser, S., Allan, H., Burr, L., Chang, A., Holmes-Liew, C. -L., Hunter, C., Jackson, D., King, P., Maguire, G., Middleton, P., Smith, D., Thomson, R., Waterer, G. W., Wong, C. and Morgan, L. (2017). The Australasian Bronchiectasis Registry - Early Steps In Mapping The Impact Of Bronchiectasis In Australia And New Zealand. International Conference of the American-Thoracic-Society (ATS), Washington Dc, May 19-24, 2017. NEW YORK: AMER THORACIC SOC. |
|
2016 Journal Article Macrolide treatment inhibits Pseudomonas aeruginosa quorum sensing in non-cystic fibrosis bronchiectasis. An analysis from the bronchiectasis and low-dose erythromycin study trialBurr, Lucy D., Rogers, Geraint B., Chen, Alice C.-H., Hamilton, Brett R., Pool, Gertruida F., Taylor, Steven L., Venter, Deon, Bowler, Simon D., Biga, Sally and McGuckin, Michael A. (2016). Macrolide treatment inhibits Pseudomonas aeruginosa quorum sensing in non-cystic fibrosis bronchiectasis. An analysis from the bronchiectasis and low-dose erythromycin study trial. Annals of the American Thoracic Society, 13 (10), 1697-1703. doi: 10.1513/AnnalsATS.201601-044OC |
|
2016 Journal Article Culture-independent detection of nontuberculous mycobacteria in clinical respiratory samplesScoleri, Gianny P., Choo, Jocelyn M., Leong, Lex E. X., Goddard, Thomas R., Shephard, Lisa, Burr, Lucy D., Bastian, Ivan, Thomson, Rachel M. and Rogers, Geraint B. (2016). Culture-independent detection of nontuberculous mycobacteria in clinical respiratory samples. Journal of Clinical Microbiology, 54 (9), 2395-2398. doi: 10.1128/JCM.01410-16 |
|
2016 Journal Article FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasisTaylor, Steven L., Woodman, Richard J., Chen, Alice C. H., Burr, Lucy D., Gordon, David L., McGuckin, Michael A., Wesselingh, Steve and Rogers, Geraint B. (2016). FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis. Thorax, 72 (4), 304-310. doi: 10.1136/thoraxjnl-2016-208775 |
|
2015 Journal Article Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasisTaylor, Steven L., Rogers, Geraint B., Chen, Alice C.-H., Burr, Lucy D., McGuckin, Michael A. and Serisier, David J. (2015). Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis. Annals of the American Thoracic Society, 12 (5), 701-707. doi: 10.1513/AnnalsATS.201411-513OC |
|
2015 Journal Article Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activationChen, Alice C.-H., Martin, Megan L., Lourie, Rohan, Rogers, Geraint B., Burr, Lucy D., Hasnain, Sumaira Z., Bowler, Simon D., McGuckin, Michael A. and Serisier, David J. (2015). Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation. PLoS ONE, 10 (3) e0119325, e0119325. doi: 10.1371/journal.pone.0119325 |
